14-day Premium Trial Subscription Sign Up For FreeGet Free

Alexion Pharmaceuticals Stock Forecast NASDAQ:ALXN

$182.50 (0%)

Volume: 0

Closed: Dec 03, 2021

Hollow Logo Score: 0.000

Alexion Pharmaceuticals Stock Forecast

$182.50 (0%)

Volume: 0

Closed: Dec 03, 2021

Score Hollow Logo 0.000
Which way will ALXN go? Request
Fri, Dec 03, 2021
Stop-loss: $171.55 (-6.00%)
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 50 and the stock is currently not being overbought or oversold

Alexion Pharmaceuticals stock price ended on $182.50 on Friday after losing 0%
(Updated on Dec 03, 2021)


ALXN Insider Trading Show all Trades

INSIDER POWER

0.655

Last 100 transactions
Buy: 1 191 884 | Sell: 1 818 931 (Shares)
Date Action Amount Person Type
Jul 21, 2021 Sell 60 207 Bazarko Daniel Common Stock, par value $.0001 per share
Jul 21, 2021 Sell 12 840 Friedman Paul A Common Stock, par value $.0001 per share
Jul 21, 2021 Sell 14 629 Dunsire Deborah Common Stock, par value $.0001 per share
Jul 21, 2021 Sell 15 336 Mollen John T Common Stock, par value $.0001 per share
Jul 21, 2021 Sell 56 762 Hantson Ludwig Option to Purchase Common Stock
Show all Insider Trades
INSIDER POWER

0.655

Last 100 transactions
Buy: 1 191 884 | Sell: 1 818 931 (Shares)

Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT